Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells.

Audigé A, Rochat MA, Li D, Ivic S, Fahrny A, Muller CKS, Gers-Huber G, Myburgh R, Bredl S, Schlaepfer E, Scherrer AU, Kuster SP, Speck RF.

BMC Immunol. 2017 May 30;18(1):28. doi: 10.1186/s12865-017-0209-9.

2.

Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.

Myburgh R, Ivic S, Pepper MS, Gers-Huber G, Li D, Audigé A, Rochat MA, Jaquet V, Regenass S, Manz MG, Salmon P, Krause KH, Speck RF.

J Virol. 2015 Jul;89(13):6761-72. doi: 10.1128/JVI.00277-15. Epub 2015 Apr 22.

3.

Modeling HIV infection and therapies in humanized mice.

Nischang M, Gers-Huber G, Audigé A, Akkina R, Speck RF.

Swiss Med Wkly. 2012 Jul 9;142:w13618. doi: 10.4414/smw.2012.13618. eCollection 2012. Review.

4.

Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1.

Nischang M, Sutmuller R, Gers-Huber G, Audigé A, Li D, Rochat MA, Baenziger S, Hofer U, Schlaepfer E, Regenass S, Amssoms K, Stoops B, Van Cauwenberge A, Boden D, Kraus G, Speck RF.

PLoS One. 2012;7(6):e38853. doi: 10.1371/journal.pone.0038853. Epub 2012 Jun 13.

5.

Influenza virus partially counteracts restriction imposed by tetherin/BST-2.

Mangeat B, Cavagliotti L, Lehmann M, Gers-Huber G, Kaur I, Thomas Y, Kaiser L, Piguet V.

J Biol Chem. 2012 Jun 22;287(26):22015-29. doi: 10.1074/jbc.M111.319996. Epub 2012 Apr 6.

6.

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.

Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V.

PLoS Pathog. 2009 Sep;5(9):e1000574. doi: 10.1371/journal.ppat.1000574. Epub 2009 Sep 4.

Supplemental Content

Loading ...
Support Center